Literature DB >> 18267270

Parkinsonism & related disorders. Ataxias.

Thomas Klockgether1.   

Abstract

The ataxias are a group of progressive neurodegenerative disorders with ataxia as the leading symptom. Current classifications distinguish between hereditary and non-hereditary ataxias. The hereditary ataxias are further divided into the autosomal recessive ataxias, the most frequent of which is Friedreich's ataxia, and the autosomal dominant spinocerebellar ataxias. The non-hereditary ataxias are separated into the acquired ataxias, such as alcoholic cerebellar degeneration or paraneoplastic cerebellar degeneration, and the sporadic degenerative ataxias, such as multiple system atrophy or sporadic adult onset ataxia. The causative mutations of many hereditary ataxias have recently been identified. Therapies based on the knowledge of the underlying molecular pathogenesis are available for a number of ataxia disorders.

Entities:  

Mesh:

Year:  2007        PMID: 18267270     DOI: 10.1016/S1353-8020(08)70036-1

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  9 in total

Review 1.  Emerging therapies in Friedreich's ataxia.

Authors:  Tanya V Aranca; Tracy M Jones; Jessica D Shaw; Joseph S Staffetti; Tetsuo Ashizawa; Sheng-Han Kuo; Brent L Fogel; George R Wilmot; Susan L Perlman; Chiadi U Onyike; Sarah H Ying; Theresa A Zesiewicz
Journal:  Neurodegener Dis Manag       Date:  2016

2.  Efficacy and Tolerability of Interferon Gamma in Treatment of Friedreich's Ataxia: Retrospective Study.

Authors:  Mehmet Fatih Yetkİn; Murat GÜltekİn
Journal:  Noro Psikiyatr Ars       Date:  2020-09-21       Impact factor: 1.339

Review 3.  Emerging therapies in Friedreich's Ataxia.

Authors:  Theresa A Zesiewicz; Joshua Hancock; Shaila D Ghanekar; Sheng-Han Kuo; Carlos A Dohse; Joshua Vega
Journal:  Expert Rev Neurother       Date:  2020-09-21       Impact factor: 4.618

4.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

5.  Loss of intrinsic organization of cerebellar networks in spinocerebellar ataxia type 1: correlates with disease severity and duration.

Authors:  Ana Solodkin; Eitan Peri; E Elinor Chen; Eshel Ben-Jacob; Christopher M Gomez
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

6.  A randomized pilot study of stochastic vibration therapy in spinocerebellar ataxia.

Authors:  O Kaut; H Jacobi; C Coch; A Prochnicki; M Minnerop; T Klockgether; U Wüllner
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

Review 7.  Role of Microglia in Ataxias.

Authors:  Austin Ferro; Carrie Sheeler; Juao-Guilherme Rosa; Marija Cvetanovic
Journal:  J Mol Biol       Date:  2019-01-18       Impact factor: 5.469

8.  Neuroprotective role of liver growth factor "LGF" in an experimental model of cerebellar ataxia.

Authors:  Lucía Calatrava-Ferreras; Rafael Gonzalo-Gobernado; Diana Reimers; Antonio S Herranz; Adriano Jiménez-Escrig; Juan José Díaz-Gil; María José Casarejos; María Teresa Montero-Vega; Eulalia Bazán
Journal:  Int J Mol Sci       Date:  2014-10-21       Impact factor: 5.923

9.  Effects of intravenous administration of human umbilical cord blood stem cells in 3-acetylpyridine-lesioned rats.

Authors:  Lucía Calatrava-Ferreras; Rafael Gonzalo-Gobernado; Antonio S Herranz; Diana Reimers; Teresa Montero Vega; Adriano Jiménez-Escrig; Luis Alberto Richart López; Eulalia Bazán
Journal:  Stem Cells Int       Date:  2012-10-24       Impact factor: 5.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.